Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in foreign holdings of KRX Stocks as of Feb 9th which has an aggregated holding worth USD509.9bn.</li>
<li>We estimate that foreign flows to be inflows of USD2,322mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign instistutions.</li>
<li>We highlight foreign changes in Hyundai Motor, Samsung Electronics, Kia, Sk Square, Samsung C&amp;T.</li>
</ul>


We analyzed the changes in foreign holdings of KRX Stocks as of Feb 9th which has an aggregated holding worth USD509.9bn.
We estimate that foreign flows to be inflows of USD2,322mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign instistutions.
We highlight foreign changes in Hyundai Motor, Samsung Electronics, Kia, Sk Square, Samsung C&amp;T.


KRX Foreign Holding Weekly (Feb 9th): Hyundai Motor, Samsung Electronics, Kia, Sk Square

<ul>
<li>We analyzed the changes in foreign holdings of KRX Stocks as of Feb 2nd which has an aggregated holding worth USD509.3bn.</li>
<li>We estimate that foreign flows to be inflows of USD1,941mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign instistutions.</li>
<li>We highlight foreign changes in Samsung Electronics, Kia, Samsung C&amp;T, Hyundai Motor, Samsung Biologic.</li>
</ul>


We analyzed the changes in foreign holdings of KRX Stocks as of Feb 2nd which has an aggregated holding worth USD509.3bn.
We estimate that foreign flows to be inflows of USD1,941mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign instistutions.
We highlight foreign changes in Samsung Electronics, Kia, Samsung C&amp;T, Hyundai Motor, Samsung Biologic.


KRX Foreign Holding Weekly (Feb 2nd): Samsung Electronics, Kia, Samsung C&T, Hyundai Motor

<ul>
<li>We analyzed the changes in foreign holdings of KRX Stocks as of Jan 26th which has an aggregated holding worth USD476.8bn.</li>
<li>We estimate that foreign flows to be inflows of USD1,189mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.</li>
<li>We highlight foreign changes in Samsung Electronics, Ecopro, Samsung Biologic, Samsung SDI.</li>
</ul>


We analyzed the changes in foreign holdings of KRX Stocks as of Jan 26th which has an aggregated holding worth USD476.8bn.
We estimate that foreign flows to be inflows of USD1,189mln. We tabulate the league table for top changes by value for 1W/4W/1Y and top stocks held by foreign institutions.
We highlight foreign changes in Samsung Electronics, Ecopro, Samsung Biologic, Samsung SDI.


KRX Foreign Holding Weekly (Jan 26th): Samsung Electronics, Ecopro, Samsung Biologic, Samsung SDI

Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/samsung-biologics-co-ltd" target="_blank" data-smartkarma-citation="entities:22932:1" rel="noopener">Samsung Biologics (207940 KS)</a> reported 11% YoY growth in revenue to KRW1.07 trillion in 4Q23 driven by the ramp-up of operation of its Plant 4 and robust sales backlog.</li>
<li>The company closed 2023 with record high revenue and operating profit, bucking the weakening trend in overall global CDMO sector.</li>
<li>The outlook remains strong, with resilient business performance expected to drive a 10–15% annual growth in revenue for 2024.</li>
</ul>



Samsung Biologics (207940 KS) reported 11% YoY growth in revenue to KRW1.07 trillion in 4Q23 driven by the ramp-up of operation of its Plant 4 and robust sales backlog.
The company closed 2023 with record high revenue and operating profit, bucking the weakening trend in overall global CDMO sector.
The outlook remains strong, with resilient business performance expected to drive a 10–15% annual growth in revenue for 2024.


Samsung Biologics (207940 KS): Stellar Performance in 4Q23; Outlook Remains Strong

<ul>
<li>We analyzed the changes in short interest of KRX Stocks as of Jan 19th which has an aggregated short interest worth USD8.4bn.</li>
<li>We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in POSCO Future, LG Energy Solution.</li>
</ul>


We analyzed the changes in short interest of KRX Stocks as of Jan 19th which has an aggregated short interest worth USD8.4bn.
We tabulate league table for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in POSCO Future, LG Energy Solution.


KRX Short Interest Weekly (Jan 19th): POSCO Future, LG Energy Solution

South Korea

Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Samsung Biologics (207940 KS)

KRX Foreign Holding Weekly (Feb 9th): Hyundai Motor, Samsung Electronics, Kia, Sk Square

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Hyundai Motor, Samsung Electronics, Kia, Sk...

Ke Yan, CFA, FRM

KRX Foreign Holding Weekly (Feb 2nd): Samsung Electronics, Kia, Samsung C&T, Hyundai Motor

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Kia, Samsung C&T, Hyundai...

Ke Yan, CFA, FRM

KRX Foreign Holding Weekly (Jan 26th): Samsung Electronics, Ecopro, Samsung Biologic, Samsung SDI

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, Ecopro, Samsung Biologic,...

Ke Yan, CFA, FRM